Global stocks steadied on Friday ahead of key U.S. payrolls data, with investors cautiously optimistic that the world might ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...